Showing results (481-490 of 615) with videos related to
Sort By:
Pageof 62
American Journal of Hematology|October 1, 1984
Marrow transplantation in hepatitis-associated aplastic anemiaR P Witherspoon, R Storb, H Shulman, et al.Bone Marrow Transplantation|June 1, 1990
Gynecological abnormalities following allogeneic bone marrow transplantationM A Schubert, K M Sullivan, M M Schubert, et al.Bone Marrow Transplantation|January 1, 1995
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignanciesM H Lynch, F B Petersen, F R Appelbaum, et al.Annals of Internal Medicine|May 1, 1984
Allogeneic marrow transplantation in the treatment of preleukemiaF R Appelbaum, R Storb, R E Ramberg, et al.Hematological Oncology|April 1, 1983
Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantationF R Appelbaum, E D Thomas, C D Buckner, et al.Blood|April 1, 1994
Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiationR A Nash, F G Schuening, K Seidel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemiaR A Clift, C D Buckner, F R Appelbaum, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 1995
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trialT Demirer, F B Petersen, F R Appelbaum, et al.Blood|April 1, 1996
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantationJ E Sanders, J Hawley, W Levy, et al.Blood|April 1, 1993
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresisW I Bensinger, T H Price, D C Dale, et al.Pageof 62